Talk:Mitomycins

Requested move 31 December 2023

 * The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.

The result of the move request was: moved. (closed by non-admin page mover) Vanderwaalforces (talk) 13:26, 17 January 2024 (UTC)

Mitomycin → Mitomycins – This article is about mitomycins. Mitomycin, as the article notes, generally refers to Mitomycin-c, and Mitomycin should redirect there after the move. @Boghog, thanks for fixing my last edit. Agree? RudolfoMD (talk) 08:32, 31 December 2023 (UTC) — Relisting. SkyWarrior  16:43, 7 January 2024 (UTC)
 * Hi RudolfoMD. Since the INN for the drug is Mitomycin and the drug is probably the WP:PRIMARYTOPIC, I agree that Mitomycin-C should be moved to Mitomycin.  The only remaining question is what to call the current Mitomycin article.  Per WP:PLURAL, the singular is generally preferred, but the plural may be used for  groups or classes of specific things. Therefore "Mitomycins" should work.  However some might find it confusing to have on article on Mitomycin and a second on Mitomycins.  Perhaps it would be better to move the current article to "Mitomycin (natural product)".  Cheers. Boghog (talk) 09:51, 31 December 2023 (UTC)
 * Hi, Thanks for the input. I think my proposal, under which Mitomycin will be just a redirect to "Mitomycin-c" is less confusing.  I read your comment as being OK with either.  This has been up for 7 days, but I'll wait more, as SkyWarrior recently notified folks. RudolfoMD (talk) 06:01, 11 January 2024 (UTC)
 * Note: WikiProject Pharmacology has been notified of this discussion. SkyWarrior  16:43, 7 January 2024 (UTC)
 * Note: WikiProject Chemicals has been notified of this discussion. SkyWarrior  16:43, 7 January 2024 (UTC)

The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.